PORT WASHINGTON, N.Y., May 13, 2024 /PRNewswire/ -- EQUASHIELD ®, a global leader in the development and distribution of Closed System Transfer Devices (CSTDs) and pharmacy automation solutions, marks ...
PORT WASHINGTON, N.Y., Dec. 3, 2025 /PRNewswire/ -- EQUASHIELD ®, a global leader in Closed System Transfer Devices (CSTD) and pharmacy automation, will highlight its fully integrated hazardous drug ...
Equashield is the first to introduce CSTDs to Romania, helping protect healthcare workers in light of increased demand for chemotherapy drugs PORT WASHINGTON, New ...
Equashield (equashield.com), a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, announced today a distribution partnership with Saudi Arabia-based Max Care Medical. Max ...
PORT WASHINGTON, N.Y., Aug. 25, 2022 /PRNewswire/ -- Equashield, a leading provider of closed system transfer devices (CSTDs) for hazardous drugs, today announced that its state-of-the-art, automated ...
Equashield will hold demonstrations of the only closed-back CSTD and Equashield PRO at ASHP Midyear Meeting in Las Vegas, Nevada. The Equashield CSTD provides unparalleled safety and ease of use for ...
PORT WASHINGTON, N.Y., Sept. 8, 2023 /PRNewswire/ -- EQUASHIELD, a pioneer in closed system transfer devices (CSTDs) and automated pharmacy compounding solutions, is thrilled to announce its ...
CellSHIELD ® addresses critical challenges in cell and gene therapy manufacturing by reducing cost, improving efficiency, and supporting product safety. Its fully closed design ensures sterility and ...
Equashield Remains the Provider of Choice and Most Considered Closed System Transfer Device for Pharmacists and Oncology Nurses in Prevention of Hazardous Drug Exposure A growing number of facilities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results